ABSTRACT
Increasing numbers of persons in the United States cannot speak, read, write, or understand the English language at a level that permits them to interact effectively. These limitations can hamper encounters between patients and healthcare providers, often leading to misunderstandings as to diagnosis and treatment, which in turn may result in poor patient compliance, unsatisfactory outcomes, and increased costs. A questionnaire was developed and distributed to clinical practice managers at the University of Maryland School of Medicine to assess the needs for language interpretation services and resources among clinical faculty providing healthcare to persons with limited English proficiency (LEP). Literature review, search of key Web sites, and consultation with national experts on issues pertaining to language access, health services, and reimbursement strategies also were done. Then, recommendations regarding the costs and benefits of language interpretation in healthcare settings were developed. Because recipients of federal financial assistance from the Department of Health and Human Services must provide meaningful access to persons with LEP at no cost to the client, there are clear benefits to providing language interpretation. Providers and managers should be made aware of interpretation service options and cost-saving strategies.
Subject(s)
Communication , Professional-Patient Relations , Health Services Research , Humans , Maryland , Surveys and Questionnaires , United StatesSubject(s)
Peripheral Vascular Diseases/epidemiology , Aortic Aneurysm, Abdominal/diagnosis , Aortic Aneurysm, Abdominal/epidemiology , Carotid Artery Diseases/diagnosis , Carotid Artery Diseases/epidemiology , Cause of Death , Female , Humans , Incidence , Male , Peripheral Vascular Diseases/diagnosis , Risk Factors , Sex Factors , United States/epidemiologySubject(s)
Arterial Occlusive Diseases/epidemiology , Arterial Occlusive Diseases/surgery , Lower Extremity/blood supply , Lower Extremity/pathology , Aorta/pathology , Aorta/physiopathology , Aorta/surgery , Arterial Occlusive Diseases/physiopathology , Female , Femoral Artery/pathology , Femoral Artery/physiopathology , Femoral Artery/surgery , Humans , Iliac Artery/pathology , Iliac Artery/physiopathology , Iliac Artery/surgery , Lower Extremity/physiopathology , Male , Risk Factors , Sex Factors , Vascular Patency/physiologySubject(s)
Endarterectomy, Carotid , Brain Ischemia/epidemiology , Brain Ischemia/etiology , Brain Ischemia/prevention & control , Carotid Artery, Internal/pathology , Carotid Artery, Internal/surgery , Carotid Stenosis/complications , Carotid Stenosis/epidemiology , Carotid Stenosis/surgery , Female , Humans , Male , Prevalence , Sex Factors , Stroke/epidemiology , Stroke/etiology , Stroke/prevention & control , Treatment Outcome , United States/epidemiologySubject(s)
Aortic Aneurysm, Abdominal/surgery , Aortic Rupture/surgery , Vascular Surgical Procedures , Aortic Aneurysm, Abdominal/epidemiology , Aortic Rupture/epidemiology , Female , Humans , Male , Prevalence , Risk Factors , Sex Factors , Time Factors , Treatment Outcome , United Kingdom/epidemiology , United States/epidemiologyABSTRACT
We describe a case of severe coagulopathy after mesenteric revascularization. Laboratory investigation results revealed the presence of plasma inhibitors of factor V believed to result from exposure to bovine thrombin used for intraoperative hemostasis. Vascular and cardiothoracic surgeons commonly use topical thrombin for surgical hemostasis, and many patients undergo multiple exposure. More patients likely have factor V inhibitors develop than has previously been realized, and this may account for some otherwise unexplained postoperative coagulation disorders. This report may alert surgeons to coagulation disturbances that can result from exposure to bovine thrombin and provide guidelines for diagnosis and management.
